SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-24-006263
Filing Date
2024-05-15
Accepted
2024-05-15 06:02:35
Documents
7
Period of Report
2024-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K fsd_6k.htm 6-K 11049
2 FINANCIAL STATEMENTS fsd_ex991.htm EX-99.1 709203
3 MANAGEMENT DISCUSION AND ANALYSIS fsd_ex992.htm EX-99.2 307223
4 CEO fsd_ex993.htm EX-99.3 10699
5 CFO fsd_ex994.htm EX-99.4 10908
6 fsd_ex994img3.jpg GRAPHIC 3540
7 fsd_ex993img4.jpg GRAPHIC 4266
  Complete submission text file 0001654954-24-006263.txt   1061191
Mailing Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4
Business Address FIRST CANADIAN PLACE 100 KING STREET WEST, SUITE 4000 TORONTO A6 M5X 1A4 (416) 854-8884
FSD Pharma Inc. (Filer) CIK: 0001771885 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39152 | Film No.: 24946889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)